These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 28497921)
1. Macrolide Resistance and Its Impacts on M. Pneumoniae Pneumonia in Children: Comparison of Two Recent Epidemics in Korea. Kim JH; Kim JY; Yoo CH; Seo WH; Yoo Y; Song DJ; Choung JT Allergy Asthma Immunol Res; 2017 Jul; 9(4):340-346. PubMed ID: 28497921 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia. Seo YH; Kim JS; Seo SC; Seo WH; Yoo Y; Song DJ; Choung JT Korean J Pediatr; 2014 Apr; 57(4):186-92. PubMed ID: 24868216 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical manifestations of macrolide resistant Lee E; Cho HJ; Hong SJ; Lee J; Sung H; Yu J Korean J Pediatr; 2017 May; 60(5):151-157. PubMed ID: 28592978 [TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Macrolide-Refractory Choi YJ; Chung EH; Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Cho Y; Seo JH; Sol IS; Sung M; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung HL; Choi SM; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ; Suh DI J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054002 [No Abstract] [Full Text] [Related]
5. Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia. Sung M; Roh EJ; Lee ES; Lee JY; Kim HB; Ahn Y; Eun BW; Kim JK; Kim HY; Jung SS; Kim M; Kang EK; Yang EA; Lee SJ; Park Y; Seo JH; Lee E; Yang ES; Cho HM; Shin M; Chung HL; Jang YY; Choi BS; Kim H; Jung JA; You ST; Lee MH; Kim JT; Kim BS; Hwang YH; Shim JY; Yang HJ; Han MY; Yew HY; Kim DH; Jeong SO; Whang K; Lee E; Jeon YH; Chung EH Clin Respir J; 2022 Nov; 16(11):756-767. PubMed ID: 36205104 [TBL] [Abstract][Full Text] [Related]
6. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701 [TBL] [Abstract][Full Text] [Related]
7. Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant Lee H; Choi YY; Sohn YJ; Kim YK; Han MS; Yun KW; Kim K; Park JY; Choi JH; Cho EY; Choi EH Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33671151 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant Choi JH; Seong GM; Ko Y; Kim YR; Kim C Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744 [No Abstract] [Full Text] [Related]
10. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China. Qu J; Chen S; Bao F; Gu L; Cao B Int J Infect Dis; 2019 Jun; 83():26-31. PubMed ID: 30926541 [TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju. Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608 [TBL] [Abstract][Full Text] [Related]
12. Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA. Lanata MM; Wang H; Everhart K; Moore-Clingenpeel M; Ramilo O; Leber A Emerg Infect Dis; 2021 Jun; 27(6):1588-1597. PubMed ID: 34013867 [TBL] [Abstract][Full Text] [Related]
13. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases. Li P; Wang W; Zhang X; Pan J; Gong L Sci Rep; 2024 Mar; 14(1):5632. PubMed ID: 38453960 [TBL] [Abstract][Full Text] [Related]
14. The molecular characteristics, diagnosis, and treatment of macrolide-resistant Leng M; Yang J; Zhou J Front Pediatr; 2023; 11():1115009. PubMed ID: 36937963 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hara K; Hazama K; Watanabe T; Yamanaka T; Sasaki S; Furuyama H; Shibata M; Shida S; Ishizaka A; Tabata Y; Aoyagi H; Naito H; Yoshioka M; Horino A; Kenri T; PLoS One; 2017; 12(3):e0173635. PubMed ID: 28288170 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of resistance acquisition and treatment of macrolide-resistant Yang HJ; Song DJ; Shim JY Korean J Pediatr; 2017 Jun; 60(6):167-174. PubMed ID: 28690643 [No Abstract] [Full Text] [Related]
17. The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: A retrospective study. Yen MH; Yan DC; Wang CJ; Tsao KC; Huang YC; Cheng SW; Chiu CH; Huang YC; Lin TY J Microbiol Immunol Infect; 2023 Jun; 56(3):634-640. PubMed ID: 36737359 [TBL] [Abstract][Full Text] [Related]
18. The clinical significance of macrolide resistance in pediatric Jiang TT; Sun L; Wang TY; Qi H; Tang H; Wang YC; Han Q; Shi XQ; Bi J; Jiao WW; Shen AD Front Cell Infect Microbiol; 2023; 13():1181402. PubMed ID: 37249975 [TBL] [Abstract][Full Text] [Related]
19. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018. Zhao S; Musa SS; Qin J; He D Int J Infect Dis; 2019 Apr; 81():251-253. PubMed ID: 30822543 [TBL] [Abstract][Full Text] [Related]
20. Macrolide-Resistant and Macrolide-Sensitive Han HY; Park KC; Yang EA; Lee KY J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33810090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]